Brief: Nuvasive Receives Latest FDA 510(K) Clearance For Pulse Platform And Announces Commercial Launch
30/07/2021 12:07
July 30 (Reuters) - NuVasive Inc NUVA.O :
* NUVASIVE RECEIVES LATEST FDA 510(K) CLEARANCE FOR PULSE
PLATFORM
AND ANNOUNCES COMMERCIAL LAUNCH
Source text for Eikon: ID:nPreRJphLa
Further company coverage: NUVA.O
Recent news on NuVasive
See all newsJackson Financial to join small-cap S&P 600; shares climb
NuVasive Inc reports results for the quarter ended in June - Earnings Summary
Brief: NuVasive Q2 Adjusted EPS USD 0.56 Vs. IBES Estimate USD 0.55
NuVasive Inc expected to post earnings of 55 cents a share - Earnings Preview
Brief: NuVasive Borrows $350 Mln In Revolving Loans Under 2020 Facility